Literature DB >> 33574087

Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.

Yutaka Kurebayashi1, Colleen P Olkowski2, Kelly C Lane3, Olga V Vasalatiy3, Biying C Xu3, Ryuhei Okada1, Aki Furusawa1, Peter L Choyke1, Hisataka Kobayashi1, Noriko Sato4.   

Abstract

Regulatory T cells (Tregs) are known to inhibit antitumor immunity, yet the specific mechanism by which intratumoral Tregs promote tumor growth remains unclear. To better understand the roles of intratumoral Tregs, we selectively depleted tumor-infiltrating Tregs using anti-CD25-F(ab')2 near-infrared photoimmunotherapy. Depletion of tumor-infiltrating Tregs induced transient but synchronized IFNγ expression in CD8 T and natural killer (NK) cells. Despite the small fraction of CD8 T and NK cells contained within examined tumors, IFNγ produced by these CD8 T and NK cells led to efficient and rapid tumor vessel regression, intratumoral ischemia, and tumor necrosis/apoptosis and growth suppression. IFNγ receptor expression on vascular endothelial cells was required for these effects. Similar findings were observed in the early phase of systemic Treg depletion in tumor-bearing Foxp3DTR mice; combination with IL15 therapy further inhibited tumor growth and achieved increased complete regression. These results indicate the pivotal roles of intratumoral Tregs in maintaining tumor vessels and tumor growth by suppressing CD8 T and NK cells from producing IFNγ, providing insight into the mechanism of Treg-targeting therapies. SIGNIFICANCE: Intratumoral Treg depletion induces synchronized intratumoral CD8 T- and NK-cell activation, IFNγ-dependent tumor vessel regression, and ischemic tumor necrosis/apoptosis, indicating the roles of intratumoral Tregs to support the tumor vasculature. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/81/11/3092/F1.large.jpg. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33574087      PMCID: PMC8178213          DOI: 10.1158/0008-5472.CAN-20-2673

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  39 in total

1.  PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.

Authors:  Steven Song; Andrew J Ewald; William Stallcup; Zena Werb; Gabriele Bergers
Journal:  Nat Cell Biol       Date:  2005-08-21       Impact factor: 28.824

2.  Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis.

Authors:  Dana Briesemeister; Daniel Sommermeyer; Christoph Loddenkemper; Rainer Loew; Wolfgang Uckert; Thomas Blankenstein; Thomas Kammertoens
Journal:  Int J Cancer       Date:  2010-03-23       Impact factor: 7.396

3.  Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy.

Authors:  Kazuhide Sato; Noriko Sato; Biying Xu; Yuko Nakamura; Tadanobu Nagaya; Peter L Choyke; Yoshinori Hasegawa; Hisataka Kobayashi
Journal:  Sci Transl Med       Date:  2016-08-17       Impact factor: 17.956

Review 4.  The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.

Authors:  Thomas A Waldmann
Journal:  Nat Rev Immunol       Date:  2006-08       Impact factor: 53.106

Review 5.  Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.

Authors:  Rakesh K Jain
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

Review 6.  Regulatory circuits of T cell function in cancer.

Authors:  Daniel E Speiser; Ping-Chih Ho; Grégory Verdeil
Journal:  Nat Rev Immunol       Date:  2016-08-16       Impact factor: 53.106

Review 7.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.

Authors:  Susanna Purhonen; Jarmo Palm; Derrick Rossi; Nina Kaskenpää; Iiro Rajantie; Seppo Ylä-Herttuala; Kari Alitalo; Irving L Weissman; Petri Salven
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

9.  Near-Infrared Photoimmunotherapy of Cancer.

Authors:  Hisataka Kobayashi; Peter L Choyke
Journal:  Acc Chem Res       Date:  2019-07-23       Impact factor: 22.384

10.  Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer.

Authors:  Thomas A Waldmann; Milos D Miljkovic; Kevin C Conlon
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

View more
  6 in total

1.  Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity.

Authors:  Ryuhei Okada; Takuya Kato; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Peter L Choyke; Hisataka Kobayashi
Journal:  Adv Ther (Weinh)       Date:  2021-02-24

2.  PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model.

Authors:  Jiefu Jin; Ishwarya Sivakumar; Yelena Mironchik; Balaji Krishnamachary; Flonné Wildes; James D Barnett; Chien-Fu Hung; Sridhar Nimmagadda; Hisataka Kobayashi; Zaver M Bhujwalla; Marie-France Penet
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.575

Review 3.  Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies.

Authors:  Jessica Waibl Polania; Emily C Lerner; Daniel S Wilkinson; Alexandra Hoyt-Miggelbrink; Peter E Fecci
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

4.  Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma.

Authors:  Caixu Pan; Qinchuan Wu; Shuai Wang; Zhibin Mei; Lele Zhang; Xingxing Gao; Junjie Qian; Zhentian Xu; Ke Zhang; Rong Su; Danjing Guo; Lin Zhou; Shusen Zheng
Journal:  Oncoimmunology       Date:  2022-05-06       Impact factor: 8.110

Review 5.  Tumor accomplice: T cell exhaustion induced by chronic inflammation.

Authors:  Liguang Fang; Kunjing Liu; Cun Liu; Xiaomin Wang; Wenzhe Ma; Wenhua Xu; Jibiao Wu; Changgang Sun
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

6.  A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer.

Authors:  Sheng Liu; Wenting Tang; Jing Cao; Mei Shang; Hengchang Sun; Jiao Gong; Bo Hu
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.